<DOC>
	<DOCNO>NCT01129531</DOCNO>
	<brief_summary>This study evaluate safety efficacy AGN-214868 patient postherpetic neuralgia ( PHN ) - nerve pain .</brief_summary>
	<brief_title>A Study Safety Efficacy AGN-214868 Patients With Postherpetic Neuralgia</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<criteria>Persistent postherpetic neuralgia ( PHN ) nerve pain present least 9 month onset herpes zoster skin rash Female patient reproductive potential Active herpes zoster skin rash Current anticipate treatment acupuncture , TNS , steroids Current anticipate use topical analgesic agent PHN Treatment botulinum toxin therapy serotype within prior 12 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>